Evaluating the Efficacy and Safety of Daridorexant Transition From BZRAs in Insomnia Patients(EASY-TIP)
NCT07733414
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
156
Enrollment
OTHER
Sponsor class
Conditions
Insomnia Disorders
Interventions
DRUG:
Daridorexant
Sponsor
Xuanwu Hospital, Beijing